Abstract
Objective: In the majority of hypertensive subjects normofiltration represents a state of preserved renal function. However, previous research has shown that some normofilterers may represent a group of former hyperfilterers with increased risk of microalbuminuria. We did a prospective study to investigate whether in hypertensive normofilterers with former glomerular hyperfiltration, clinical characteristics differ from those of true normofilterers. Design and methods: Creatinine clearance (CrCl) and albumin excretion rate (AER) were measured at entry and after 8.5 years of follow-up, in 534 young-to-middle-age stage 1 hypertensive subjects from the HARVEST (mean age 34.6±8.3 years, 69% men). Glomerular hyperfiltration was defined as a CrCl≥150 ml/min/1.73m2. Baseline ambulatory BP, 24h urinary epinephrine, echocardiographic data, and routine blood tests were also obtained. Results: At follow-up end, 442 participants were normofilterers. Of these, 395 had normal CrCl also at baseline (true normofilterers, Group 1) whereas 47 subjects had a baseline CrCl ≥150 ml/min/1.73m2 (former hyperfilterers, Group 2). Participants of Group 2 had higher age-and-sex-adjusted systolic blood pressure (p=.007) than those of Group 1. In addition, 24h urinary epinephrine (p<.001), heart rate (p=.05), ambulatory night-time BP fall (p=.004), and left ventricular end-systolic stress (p=.01) were higher in Group 2. During the follow-up, subjects of Group 2 had a greater baseline-adjusted increase in glucose than those of Group 1 (p=.03) and a tendency to the impairment in the other metabolic data. At follow-up end, microalbuminuria was 5.3% in subjects of Group 1 and was 36.2% in those of Group 2 (p<0.0001). This difference held true in a multivariable logistic regression in which several confounders, ambulatory blood pressure, baseline AER, and other risk factors were taken into account (p<0.0001). Conclusions: These data show that hypertensive normofilterers with former hyperfiltration are a distinct subgroup characterized by higher sympatho-adrenergic activity and poorer metabolic profile. These patients are at increased risk of renal damage and should be treated earlier for hypertension
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have